Sign Up to like & get
recommendations!
0
Published in 2018 at "Neuropathology and Applied Neurobiology"
DOI: 10.1111/nan.12415
Abstract: It is important to predict response to treatment with temozolomide (TMZ) in glioblastoma (GBM) patients. Both MGMT protein expression and MGMT promoter methylation status have been reported to predict the response to TMZ. We investigated…
read more here.
Keywords:
mgmt protein;
protein expression;
glioblastoma;
prognostic value ... See more keywords